BACKGROUND AND OBJECTIVES: Candidates with AKI including hepatorenal syndrome often recover renal function after successful liver transplantation (LT). This study examined the incidence and risk factors associated with renal nonrecovery within 6 months of LT alone among those receiving acute renal replacement therapy (RRT) before LT. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Scientific Registry of Transplant Recipients data were linked with Centers for Medicare and Medicaid Services ESRD data for 2112 adult deceased-donor LT-alone recipients who received acute RRT for ≤90 days before LT (February 28, 2002 to August 31, 2010). Primary outcome was renal nonrecovery (post-LT ESRD), defined as transition to chronic dialysis or waitlisting or receipt of kidney transplant within 6 months of LT. Cumulative incidence of renal nonrecovery was calculated using competing risk analysis. Cox regression identified recipient and donor predictors of renal nonrecovery. RESULTS: The cumulative incidence of renal nonrecovery after LT alone among those receiving the pre-LT acute RRT was 8.9%. Adjusted renal nonrecovery risk increased by 3.6% per day of pre-LT RRT (P<0.001). Age at LT per 5 years (P=0.02), previous-LT (P=0.01), and pre-LT diabetes (P<0.001) were significant risk factors of renal nonrecovery. Twenty-one percent of recipients died within 6 months of LT. Duration of pretransplant RRT did not predict 6-month post-transplant mortality. CONCLUSIONS: Among recipients on acute RRT before LT who survived after LT alone, the majority recovered their renal function within 6 months of LT. Longer pre-LT RRT duration, advanced age, diabetes, and re-LT were significantly associated with increased risk of renal nonrecovery.
BACKGROUND AND OBJECTIVES: Candidates with AKI including hepatorenal syndrome often recover renal function after successful liver transplantation (LT). This study examined the incidence and risk factors associated with renal nonrecovery within 6 months of LT alone among those receiving acute renal replacement therapy (RRT) before LT. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Scientific Registry of Transplant Recipients data were linked with Centers for Medicare and Medicaid Services ESRD data for 2112 adult deceased-donor LT-alone recipients who received acute RRT for ≤90 days before LT (February 28, 2002 to August 31, 2010). Primary outcome was renal nonrecovery (post-LT ESRD), defined as transition to chronic dialysis or waitlisting or receipt of kidney transplant within 6 months of LT. Cumulative incidence of renal nonrecovery was calculated using competing risk analysis. Cox regression identified recipient and donor predictors of renal nonrecovery. RESULTS: The cumulative incidence of renal nonrecovery after LT alone among those receiving the pre-LT acute RRT was 8.9%. Adjusted renal nonrecovery risk increased by 3.6% per day of pre-LT RRT (P<0.001). Age at LT per 5 years (P=0.02), previous-LT (P=0.01), and pre-LT diabetes (P<0.001) were significant risk factors of renal nonrecovery. Twenty-one percent of recipients died within 6 months of LT. Duration of pretransplant RRT did not predict 6-month post-transplant mortality. CONCLUSIONS: Among recipients on acute RRT before LT who survived after LT alone, the majority recovered their renal function within 6 months of LT. Longer pre-LT RRT duration, advanced age, diabetes, and re-LT were significantly associated with increased risk of renal nonrecovery.
Authors: K A Brensing; J Textor; J Perz; P Schiedermaier; P Raab; H Strunk; H U Klehr; H J Kramer; U Spengler; H Schild; T Sauerbruch Journal: Gut Date: 2000-08 Impact factor: 23.059
Authors: Richard Ruiz; Hiroko Kunitake; Alan H Wilkinson; Gabriel M Danovitch; Douglas G Farmer; Rafik M Ghobrial; Hasan Yersiz; Jonathan R Hiatt; Ronald W Busuttil Journal: Arch Surg Date: 2006-08
Authors: Mical S Campbell; David S Kotlyar; Colleen M Brensinger; James D Lewis; Kirti Shetty; Roy D Bloom; James F Markmann; Kim M Olthoff; Abraham Shaked; K Rajender Reddy Journal: Liver Transpl Date: 2005-09 Impact factor: 5.799
Authors: S Feng; N P Goodrich; J L Bragg-Gresham; D M Dykstra; J D Punch; M A DebRoy; S M Greenstein; R M Merion Journal: Am J Transplant Date: 2006-04 Impact factor: 8.086
Authors: Sammy Saab; Victor Wang; Ayman B Ibrahim; Francisco Durazo; Steven Han; Douglas G Farmer; Hasan Yersiz; Marcia Morrisey; Leonard I Goldstein; R Mark Ghobrial; Ronald W Busuttil Journal: Liver Transpl Date: 2003-05 Impact factor: 5.799
Authors: C L Davis; S Feng; R Sung; F Wong; N P Goodrich; L B Melton; K R Reddy; M K Guidinger; A Wilkinson; J Lake Journal: Am J Transplant Date: 2007-05-26 Impact factor: 8.086
Authors: Pratima Sharma; Nathan P Goodrich; Douglas E Schaubel; Mary K Guidinger; Robert M Merion Journal: J Am Soc Nephrol Date: 2013-09-12 Impact factor: 10.121
Authors: Andrew S Allegretti; Xavier Vela Parada; Nwamaka D Eneanya; Hannah Gilligan; Dihua Xu; Sophia Zhao; Jules L Dienstag; Raymond T Chung; Ravi I Thadhani Journal: Clin J Am Soc Nephrol Date: 2017-11-09 Impact factor: 8.237
Authors: Xun Luo; Allan B Massie; Christine E Haugen; Rashikh Choudhury; Jessica M Ruck; Ashton A Shaffer; Sheng Zhou; Dorry L Segev; Jacqueline M Garonzik-Wang Journal: Transplantation Date: 2018-04 Impact factor: 4.939